Why Alzheimer’s Trials Are Recruiting Younger Patients
Alzheimer’s is a notoriously difficult disease to identify with certainty. By the time a patient receives a diagnosis, its pathology in the brain is…
Alzheimer’s is a notoriously difficult disease to identify with certainty. By the time a patient receives a diagnosis, its pathology in the brain is…
Each of these authors shared their own unique experience with dementia in our 2021 Being Patient LiveTalks, and throughout all of these insightful, personal,…
Protollin, a new vaccine for Alzheimer’s that is administered nasally, heads to human clinical trials. Through the incredible power of our immune system, researchers…
A career journalist, newspaper and magazine editor, Greg O’Brien learned from his mother what it means to truly live with Alzheimer’s, and it was…
Jean Lee remembers her late parents for who they were in their essence, a loving and positive couple who raised her with faith and…
Roughly two thirds of Americans with Alzheimer’s are women, but it isn’t exactly clear why the disease disproportionately impacts females. Given that age is…
Analysts had high hopes for anti-amyloid drug Aduhelm — the first Alzheimer’s treatment approved by the FDA in nearly two decades and the first…
New clinical trials on memory loss interventions are currently enrolling healthy participants with key Alzhemier’s biomarkers as young as 55 years old. Tau and…
As part of an online conference hosted by the Alzheimer’s Foundation of America, Associate Professor of Medicine at New York University’s (NYU) Long Island…
Diagnosing degenerative brain diseases early and accurately is a major challenge, and it can take years before a patient receives an accurate diagnosis. But…
You may have read about it in the New York Post: “Scientists pinpoint personality traits that increase risk of Alzheimer’s.” A recent study published in…
Georg Meisl, a research associate at Yusuf Hamied Department of Chemistry, University of Cambridge shares insight into new research that sheds light on just…
Following the approval of the Alzheimer’s drug Aduhelm — and the litany of controversy surrounding it — one question that’s top of mind for…
Alzheimer’s can often be a long, drawn-out illness, and for Patti Davis, this long goodbye was also a blessing. Looking back on her late…
In our LiveTalk series, Being Patient spoke with retired physician Jennifer Bute about the early symptoms of Alzheimer’s that she began experiencing in the 2000s,…